Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: AstraZeneca UK Limited, 600 Capability Green, Luton, LU1 3LU, UK
Arimidex 1 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. White, round, biconvex film-coated tablets of about 6.1 mm marked with ‘A’ on one side and ‘Adx1’ on the other side. |
Each film-coated tablet contains 1 mg anastrozole.
Excipients with known effect: Each film-coated tablet contains 93 mg of lactose monohydrate (see section 4.4).
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Anastrozole is a potent and highly selective non-steroidal aromatase inhibitor. It inhibits the enzyme aromatase, which is responsible for converting androgens to estrogens. Anastrozole is a drug indicated in the treatment of breast cancer in post-menopausal women. |
| List of Excipients |
|---|
|
Lactose monohydrate |
PVC blister/aluminium foil packs of 20, 28, 30, 84, 98, 100 and 300 tablets contained in a carton. Not all pack sizes may be marketed.
AstraZeneca UK Limited, 600 Capability Green, Luton, LU1 3LU, UK
PL 17901/0002
Date of first authorisation: 18 June 2000
Date of latest renewal: 14 December 2013
| Drug | Countries | |
|---|---|---|
| ARIMIDEX | Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.